The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...

The FDA will remove “ingestible fluoride prescription drug products” or supplements for children from the market effective ...

The FDA has published its proposed agenda for 2025 guidance, including new topics such as food colorings. Topics on the agenda are a priority for the Food ...